BullishAgent BullishAgent Filings Economic Earnings Ratings IPOs Insiders Institutional ETFs Funds Screener
Sign in Register

MASS

908 Devices Inc. NASDAQ Listed Dec 18, 2020
Healthcare ·Medical - Devices ·US · 908devices.com
$8.08
After hrs $8.02 -0.74%
Mkt Cap $302.0M
52w Low $4.20 75.5% of range 52w High $9.34
50d MA $6.64 200d MA $6.67
P/E (TTM) 12.6x
EV/EBITDA -4.4x
P/B 1.7x
Debt/Equity 0.1x
ROE 13.6%
P/FCF -7.7x
RSI (14)
ATR (14)
Beta 0.53
50d MA $6.64
200d MA $6.67
Avg Volume 275.7K
About
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for ra…
Recent Earnings
Date Time Est Rptd Surp Base Gap% D1% D2% D3% D4% D5% Guide ▲★
May 6, 2026 BMO -0.15 -0.22 -46.7% 7.09 +7.1%
Mar 3, 2026 BMO -0.06 -0.05 +16.7% 6.32 +0.0% +6.6% +6.8% -0.9% +0.8% -0.9%
Nov 10, 2025 BMO -0.12 -0.15 -30.4% 6.40 -2.3% -7.8% -7.8% -9.2% -14.4% -15.9%
Aug 5, 2025 BMO -0.16 -0.18 -12.5% 6.34 +3.3% +3.2% +1.3% -0.2% +1.4% +2.1%
May 13, 2025 BMO -0.27 -0.22 +18.5% 4.65 +1.1% -7.1% -2.8% -1.5% +2.6% +6.2%
Mar 4, 2025 BMO -0.35 -0.32 +8.6% 3.88 +4.1% -13.1% -22.4% -28.9% -22.2% -10.8%
Nov 12, 2024 BMO -0.29 -0.23 +20.7% 2.92 -3.4% -19.9% -18.5% -18.2% -19.2% -15.1%
Aug 6, 2024 BMO -0.34 -0.32 +5.9% 4.63 +3.5% -5.0% -4.5% -6.0% -8.2% -8.2%
Apr 30, 2024 BMO -0.37 -0.33 +10.8% 5.70 -0.4% -0.4% -0.5% -0.9% -1.4% +0.0%
Mar 5, 2024 BMO -0.27 -0.23 +14.8% 6.96 +1.4% +2.7% -0.3% -1.4% -4.3% +0.9%
Recent Analyst Ratings
Date Firm Action Grade Target Base Open Gap% D1% D2% D3% D4% D5%
Aug 5 Leerink Partners Upgrade Market Perform → Outperform $6.52 $6.45 -1.1% -2.8% +0.3% -1.5% -2.9% -1.4%
Jan 15 Stephens & Co. Maintains Overweight → Overweight $1.98 $2.52 +27.3% +47.0% +46.5% +50.5% +53.0% +41.9%
Nov 13 Leerink Partners Downgrade Outperform → Market Perform $2.92 $2.82 -3.4% -19.9% -18.5% -18.2% -19.2% -15.1%
Nov 13 Stifel Maintains Buy → Buy $2.92 $2.82 -3.4% -19.9% -18.5% -18.2% -19.2% -15.1%
Oct 17 Leerink Partners Maintains Outperform → Outperform $3.53 $3.53 +0.0% -2.8% +1.7% -0.8% -2.8% -3.4%
May 13 Stephens & Co. Maintains Overweight → Overweight $5.70 $5.81 +1.9% +15.1% +25.4% +27.0% +20.7% +20.2%
Sep 25 Stephens & Co. Maintains Overweight → Overweight $6.04 $6.00 -0.7% +0.2% +1.0% +7.3% +6.3% +10.3%
Feb 7 Stephens & Co. Maintains Overweight → Overweight $9.97 $10.09 +1.2% +4.4% +3.8% +1.3% +1.8% +3.9%
Jan 6 SVB Leerink Maintains Outperform → Outperform $7.45 $7.51 +0.8% -1.9% -1.7% +9.4% +11.9% +9.7%
Nov 15 SVB Leerink Maintains Outperform → Outperform $12.48 $12.70 +1.8% -15.9% -11.8% -16.4% -20.7% -20.8%
Insider Trades
Date Insider Title Type Shares Price Value Owned After D1% D5%
May 6, 2026 Brown Christopher D. Sell 20,000 $7.23 $145K 925,559
May 1, 2026 Kenneweg John SVP, Sales & Product Marketing Sell 7,787 $6.83 $53K 76,039 +8.24%
Recent Filings
Data updated apr 25, 2026 8:36pm · Source: massive.com